Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Scandinavian Journal of Immunology|December 1, 1995
Specific interferon-gamma producing CD4+ and CD8+ T cells after autologous EBV-B stimulation: the necessity of restimulationW C Vooijs, M G Nootebos, H Wernert, et al.International Journal of Cancer|October 3, 1999
Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cellsJ Post, W C Vooijs, B J Bast, et al.Tissue Antigens|November 5, 1998
The effect of immunotoxins directed against CD80 and CD86 on primary T-cell alloresponsesH G Otten, W C Vooijs, L van der Gouw, et al.Nature Biotechnology|January 14, 2000
Resolution of cutaneous inflammation after local elimination of macrophagesT Thepen, A J van Vuuren, R C Kiekens, et al.Immunology Letters|January 1, 1996
The 'monocytic' cell line I937 displays typical B cell characteristicsI G Reischl, E M Pöllabauer, S Peiritsch, et al.Cancer Immunology, Immunotherapy : CII|July 1, 1996
Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxinsW C Vooijs, J Post, J Wijdenes, et al.British Journal of Haematology|August 1, 1996
A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1J Wijdenes, W C Vooijs, C Clément, et al.Human Immunology|September 12, 2000
IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donorsP J Baselmans, E Pöllabauer, F C van Reijsen, et al.British Journal of Cancer|January 1, 1997
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's diseaseW C Vooijs, H G Otten, M van Vliet, et al.European Journal of Clinical Investigation|March 12, 2002
Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturationP H Gosselaar, A J G van-Dijk, G C de-Gast, et al.Pageof 1